Nrg4 E47Q was demonstrated to potentiate the protective effects of Nrg4 against NAFLD in animal models by negatively regulating de novo lipogenesis, whereas Nrg4 R44H was deprived of these effects (Li et al., 2021). Here, NRG4 is linked to metabolic dysfunction-associated steatotic liver disease.